Furthermore, Western blotting and IHC analysis demonstrated, PROX1 expression was significantly higher in the human colon adenocarcinoma samples than in its corresponding non-tumor counterparts (Figure 1E, 1F). This evidence concerns the gene PROX1 and colon adenocarcinoma.